EndoQuest, an endoluminal robotics technology company, announced it closed a $42 million C-1 preferred financing round.
Existing investors CE Ventures Limited and McNair Interests Ltd. participated in the round, as did new investor Puma Venture Capital LLC.
WHAT IT DOES
The Houston-based company developed a flexible robotics surgery system to perform minimally invasive procedures in upper and...
Digital gastrointestinal health company Vivante Health has signed a national distribution contract with health insurer UnitedHealthcare, becoming the first digestive solution on the UHC Hub.
Vivante's GIThrive platform provides personalized care plans and allows patients to track their symptoms and access educational content and self-guided behavioral health modules. A coordinated team of...
Editor's note: This article has been updated to reflect Health Catalyst Capital not Health Catalyst participated in the round.
Digital gastrointestinal health company Vivante Health announced it closed a $31 million Series B funding round led by new investor Mercato Partners, bringing its total raise to $47 million.
Health Catalyst Capital, Intermountain Ventures, SemperVirens, 7wireVentures,...
Oshi Health, a digital gastrointestinal health company, announced that it had garnered $30 million in Series B funding.
Koch Disruptive Technologies (KDT) led the round, with participation from existing investors Flare Capital Partners, Bessemer Venture Partners, CVS Health Ventures, Frist Cressey Ventures and Takeda Digital Ventures.
WHAT IT DOES
Oshi provides patients with gastrointestinal...
Aetna, the insurer owned by CVS Health, on Thursday announced a value-based care partnership with digital gastrointestinal care startup Oshi Health.
Oshi offers virtual access to a team of providers – including a gastroenterologist, dietitian, behavioral health clinician and a health coach – to patients with digestive concerns like irritable bowel syndrome (IBS), Crohn's Disease and ulcerative...
Digital gastrointestinal care startup Salvo Health launched last week with $10.5 million in seed funding.
The round was led by Threshold Ventures with participation from Torch Capital and Felicis Ventures.
WHAT THEY DO
The startup offers a virtual clinic geared toward people with chronic gut problems, including irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD...
Auckland-based health technology startup Alimetry has received clearance from the US Food and Drug Administration for its wearable device for diagnosing gastric disorders.
Gastric Alimetry is a non-invasive test for common stomach disorders, including nausea and vomiting, gastroparesis, and functional dyspepsia.
Alongside the FDA clearance, the company announced the launch of Alimetry, Inc., its...
Digital IBS care startup metaMe Health is launching its recently FDA-approved prescription digital therapeutic using a partnership with operations and commercialization company Indegene.
Regulora, which scored an FDA 510(k) late last year, delivers gut-directed hypnotherapy to help alleviate pain associated with IBS in adults. As part of the commercialization deal, Indegene will focus on bringing...
Virtual-care company Firefly Health is partnering with digital gastrointestinal-health startup Oshi Health to offer digital digestive care.
As part of the deal, Firefly members receive access to virtual visits with a care team, including providers, dietitians and psychologists. They can also use symptom-tracking tools and message health coaches to support lifestyle changes.
"Digestive issues are...
metaMe Health has received FDA 510(k) clearance for Regulora, a prescription digital therapeutic aimed at treating abdominal pain associated with irritable bowel syndrome in adults.
Regulora is a smartphone app that delivers behavioral therapy based on gut-directed hypnotherapy to alleviate IBS pain.
“The FDA’s clearance of Regulora, our first PDT, is a major achievement for the company,” Tim...
_13.jpg?itok=lqd3KjSP "Businesspeople shaking hands")
